---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-028522"
form_type: "8-K"
ticker: "CING"
cik: "0001862150"
company_name: "Cingulate Inc."
filed_at: "2023-08-14T23:59:59+00:00"
generated_at: "2026-06-11T12:51:50.318512+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Cingulate Q2 cash $0.3M, net loss widens to $6.6M; Phase 3 adult ADHD trial misses primary endpoint

## Summary
- Cash and equivalents $0.3M at June 30, 2023; expects to fund operations only into September 2023.
- Net loss $6.6M in Q2 2023 vs $4.0M in Q2 2022; R&D expenses $4.5M vs $2.2M.
- Phase 3 adult efficacy trial of CTx-1301 did not achieve statistical significance on primary endpoint; effect size 1.79 cited.
- Private placement with WFIA: 1,823,155 shares at $0.5485, gross proceeds $1.0M, closed August 11, 2023.

## SEC filing metadata
- accession: 0001493152-23-028522
- form_type: 8-K
- ticker: CING
- cik: 0001862150
- company_name: Cingulate Inc.
- filed_at: 2023-08-14T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 2.02, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1862150/000149315223028522/0001493152-23-028522-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1862150/000149315223028522/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-028522
- JSON: https://secwatch.observer/filing/0001493152-23-028522.json
- Plain text: https://secwatch.observer/filing/0001493152-23-028522.txt

## Key facts
- Earnings Releases
  Cingulate Inc. reported financial results for the quarter ended June 30, 2023.
  - Period: the quarter ended June 30, 2023
  - Result: reported results
  source text: On August 14, 2023, the Company issued a press release announcing its financial results for the second quarter of 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1862150/000149315223028522/0001493152-23-028522-index.htm
- Material Agreements
  Cingulate Inc. entered into Securities Purchase Agreement with Werth Family Investment Associates LLC valued at aggregate gross proceeds to the Company of approximately $1.0 million (effective 2023-08-11).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: Werth Family Investment Associates LLC
  - Value: aggregate gross proceeds to the Company of approximately $1.0 million
  - Effective: 2023-08-11
  source text: On August 11, 2023, Cingulate Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with Werth Family Investment Associates LLC (“WFIA”)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1862150/000149315223028522/0001493152-23-028522-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.